VentraSciencesTrending

A two-peptide research combination pairing Selank (a tuftsin analog) and Semax (an ACTH(4-10) analog), studied for their roles in neuromodulatory signaling. For laboratory research use only.
Card fields are hosted by our payment provider, so card numbers are never received or stored by Ventra. Apple Pay, Google Pay and Link are also available at checkout.
Technical specifications
This is a two-compound research combination of Selank, a synthetic analog of the immunomodulatory peptide tuftsin, and Semax, a synthetic analog of the ACTH(4-10) fragment, both supplied as a lyophilized powder for in vitro laboratory research use only. Both peptides are characterized in the peer-reviewed Russian and international literature: Semax in studies of monoaminergic and BDNF-related neuromodulatory signaling, and Selank in studies of tuftsin-analog neuromodulatory and behavioral research models.
Research applications: Commonly used in neuromodulatory signaling studies, monoaminergic pathway research, and behavioral neuroscience research applications.
Peer-reviewed research
References are provided for qualified researchers as a starting point for literature review. Ventra Sciences makes no claims about the contents of cited works.
This product is intended strictly for in vitro laboratory research by qualified professionals. It is not for human or veterinary use and must not be used in food, drugs, diagnostics, or cosmetics. Ventra Sciences makes no medical claims regarding any compound sold. All purchasers acknowledge they will use this product solely for research purposes.
This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. All use must comply with applicable institutional, local, and federal regulations.
By purchasing from Ventra Sciences, the buyer affirms they are a qualified researcher or institution. All sales are final. The purchaser assumes full responsibility for handling, use, and regulatory compliance.
Exclusive updates and restock alerts, straight to your inbox.